April 25, 2025 — The 9th “All Blossom” Conference, organized by the Zhejiang Provincial Committee of the Democratic National Construction Association,the Zhejiang Federation of Industry and Commerce, and the China Investment Development Promotion Association, successfully concluded. Hong Kong WinHealth Pharma Group (hereinafter referred to as "WinHealth Pharma") has once again been named to the “Hangzhou Unicorn and Semi-Unicorn Enterprises List” in recognition of its outstanding industry influence and comprehensive competitiveness. This marks the fifth consecutive year that WinHealth Pharma has received this honor since 2021, underscoring the company’s sustained leadership and strong growth momentum in the pharmaceutical and healthcare sector.
Industry Leadership, Five Consecutive Years as an Industry Benchmark
The "All Blossom" Conference, as an annual event in China's innovation and entrepreneurship landscape, has consistently focused on fast-growing enterprises and emerging economic forces. This year’s conference, themed " Pushing Forward with Strength, Sailing Toward New Horizons" attracted numerous leaders from the domestic and international technology and academic sectors, along with entrepreneurs and investors. The conference highlighted cutting-edge technology, showcased Zhejiang Province's technological leadership in innovation and its dynamic entrepreneurial ecosystem, and established an important platform for the development of emerging industries. This platform not only serves to foster innovation in Zhejiang but also extends its impact across the country and globally, driving the transformation and application of innovations. WinHealth Pharma’s five consecutive years of recognition fully reflects the conference's authoritative acknowledgment of our comprehensive strength and affirms our strategy as a leading biopharmaceutical enterprise with an integrated value chain. This honor further strengthens our leadership position in the industry.
Committed to the Pharmaceutical & Healthcare Sector, Empowering the Future of the Industry
WinHealth Pharma has always focused on the development and commercialization of innovative drugs, particularly building differentiated competitive advantages in areas such as cardiovascular and renal diseases, hematologic cancers, gastrointestinal diseases, respiratory and infectious diseases, and rare diseases. In recent years, the company has accelerated the introduction of cutting-edge international products and expanded local partnerships, continuously providing patients with more accessible healthcare solutions.
Jack Wang, Chairman of Hong Kong WinHealth Pharma Group, stated:
"Being listed on the 'Hangzhou Unicorn and Semi-Unicorn Enterprises List' for five consecutive years is not only a significant recognition of WinHealth Pharma's comprehensive strength but also reflects the progress we have made in global strategic expansion and integration across the value chain. As a biopharmaceutical enterprise focused on the commercialization of original brand and innovative drug, WinHealth Pharma will continue to strengthen its core advantages, optimize its market positioning, and bring greater value to patients and society through high-quality development, making a more substantial contribution to the advancement of pharmaceutical and health sector in China.”
About WinHealth Pharma
Founded in 2006, WinHealth Pharma is a Hong Kong-headquartered biopharmaceutical company with a fully integrated value chain. The company focuses on three core areas: proprietary pharmaceutical products, CSO business, and specialty care, with a strong commitment to the development and commercialization of cutting-edge medicines. Guided by a patient-first philosophy, we are dedicated to delivering breakthrough therapies and innovative healthcare solutions to patients with cardio-renal diseases, hematologic cancers, gastrointestinal diseases, respiratory and infectious diseases, rare diseases, and other unmet medical needs. Our commitment is to improve patients’ lives through transformative treatments. With a well-established presence in China, WinHealth Pharma is actively expanding across Asia and other international markets, building a comprehensive healthcare ecosystem, driving innovation, and meeting the evolving treatment needs of patients. For more information, please visit www.winhealth.hk .